[Progress in magnetic resonance tomography of the liver: value of ultra-rapid imaging and liver-specific contrast media].
Ongoing technical improvements in magnetic resonance imaging (MRI) and the development of liver-specific contrast agents are likely to have an impact on the clinical assessment of liver disease. Technical progress towards methods of motion-free MRI and concepts of liver-specific contrast agents are presented. The potential impact of these developments on clinical medicine is discussed.
Reimer
P
P
Institut für Klinische Radiologie, Zentrale Röntgendiagnostik, Westfälische Wilhelms-Universität, Münster.
Rummeny
E J
EJ
Hamm
B
B
Mühler
A
A
Cavagna
F
F
Saini
S
S
Peters
P E
PE
D000818:Animals; D002986:Clinical Trials as Topic; D003287:Contrast Media; D006801:Humans; D007089:Image Enhancement / Q000295:instrumentation / Q000379:methods*; D008099:Liver / Q000473:pathology; D008107:Liver Diseases / Q000175:diagnosis*; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000556:secondary; D008279:Magnetic Resonance Imaging / Q000295:instrumentation / Q000379:methods*
D003287:Contrast Media
Fortschritte in der Magnetresonanztomographie der Leber: Bedeutung ultraschneller Bildgebung und leberspezifischer Kontrastmittel.